Dr. Edward M. Schaeffer: January 9, 2019





Edward Schaeffer, MD

Chief of Urology at Northwestern Medicine 

Northwestern Medicine’s Urology program, ranked #1 in Illinois for the last 20 consecutive years, received a $10 million gift to fund the creation of a new multidisciplinary institute dedicated to urologic cancers. The Polsky Urologic Cancer Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital (Polsky Urologic Cancer Institute) will offer the most comprehensive approach to treating urologic cancers, including prostate, bladder, kidney and testicular cancers.

The new Institute was made possible by a commitment of $10 million from philanthropist Michael Polsky, CEO of Invenergy and a longtime friend to Northwestern Medicine.  Northwestern Medicine is dedicated to addressing some of the biggest health issues faced by men: prostate cancer, testicular cancer, and mental health and suicide prevention. Prostate cancer is the second most common cancer in men, and rates are on the rise. Prostate cancer can often be found before symptoms start by early screening and testing the amount of prostate-specific antigen (PSA) in a man’s blood.  This screening is important because in its early stages, prostate cancer often doesn’t cause any symptoms.

Did You Know?

  •  85% of prostate cancers are detected because of abnormalities in either bloodwork or by rectal exam.
  • Family history and race are well-established risk factors for prostate cancer.
  • A man with a father or brother who developed prostate cancer is twice as likely to develop the disease.
  • Prostate biopsies do not cause cancer to spread. Thus, you can safely “take the next step” if your doctor recommends a biopsy.
  • According to the CDC, Black men have the highest incidence rate for prostate cancer in the United States and are more than twice as likely as white men to die of the disease.


Dr. Edward Schaeffer Chief of Urology at Northwestern Medicine is available for live interviews to help raise awareness about the importance of early screening for prostate cancer. He will also be able to discuss some of the latest research available and the exciting news about the new Urologic Cancer Institute being built.



Dr. Edward M. Schaeffer is the Edmund Andrews Professor and Chair of Urology at Northwestern University Feinberg School of Medicine and the Chief of Urology at Northwestern Memorial Hospital. He is an internationally recognized physician-scientist in urologic oncology, with expertise in the management of prostate cancer.  Dr. Schaeffer’s laboratory specifically focuses on the molecular biology of locally aggressive prostate cancers and the impact of race on the biology of prostate cancer. His discoveries have greatly advanced the basic scientific understanding of prostate cancer and clinical care pathways, emphasizing at-risk populations, diagnosis, treatment outcomes, and the molecular biology of lethal disease.  His work has been acknowledged as a Clinical Cancer Advance by American Society of Clinical Oncology.

Speak Your Mind